A recent meta-analysis reviewed six controlled trials involving 401 obese women with PCOS who were given liraglutide alone or as an add-on therapy to other medications used for managing the condition, such as metformin
Alpha-, Delta- and PP-cells: are they the architectural cornerstones of islet structure and co-ordination
Large-scale epidemiological studies have confirmed that metformin users have a significantly lower risk of developing various malignancies, including bladder, lung, prostate, pancreatic, head and neck, esophageal, liver, and colorectal cancers, compared to non-users [10]
Also, a comprehensive understanding of their potential mechanisms and roles in cancer development are provided